The largest database of trusted experimental protocols

9 protocols using triptolide

1

Neutrophil Nuclear Architecture Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro differentiated neutrophils from ECOMG cells were used as a model system to study nuclear architecture in response to calcium influx in neutrophils. ECOMG cells were cultured and differentiated as previously described (Zhu et al. 2017 (link)). For inhibitors, neutrophils were treated with 10 µM Triptolide (Cayman), 100 µM 5,6-dichloro-1-β-D-ribofuranosyl-1H-benzimidazole (Cayman) or 10 µM flavopiridol (Cayman) for 30 min, or 2 µM FK506 for 2 h before activation. Primary B cells were treated with 2 µM FK506 (Cayman) for 2 h before activation. Inhibitors were kept in culture during activation time course. Acute degradation was induced by treating the cells with 0.5 µM dTAG-13 (Tocris) before activation. dTAG-13 was kept in culture during activation time course. The time series degradation experiments were performed by inducing protein degradation at the beginning of the time course and harvesting the samples at different time points. RPMI-1640 (Gibco) contains 0.42 mM calcium. Additional CaCl2 was supplied to the medium before activation to a final concentration of 1 mM. A23187 was purchased from Sigma and Cayman. Neutrophils were activated either using fast activation conditions (20 µM A23187 for 15 min), or using slow activation conditions (5 µM A23187 for 4 h). These two activation conditions were used throughout the manuscript unless otherwise mentioned.
+ Open protocol
+ Expand
2

Arabidopsis Genetic Manipulation Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
The spt6l heterozygous seeds (SALK_016621), previously described (14 (link)), were obtained from the Arabidopsis Biological Resource Center (ABRC) at Ohio State University. Three formerly generated transgenic lines: ProREF6:REF6-GFP (16 (link)), ProACC1:ACC1-GFP (17 (link)) and 35S:GFP (16 (link)) were used. All Arabidopsis seeds used were in the Columbia (Col-0) background. Plants were grown either on half-strength Murashige and Skoog ( MS) medium (0.5× MS salts, 1.5% [w/v] sucrose, and 0.8% agar [pH 5.8]) or in soil under 16 h/8 h light/dark cycle at 23 °C. For the inhibitor treatment, 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole (DRB) (10010302, Cayman Chemical), flavopiridol (10009197, Cayman Chemical), or triptolide (11973, Cayman Chemical) was added to the media at a final concentration of 100, 10 and 10 μM, respectively. For the short-time treatment, 10-day-old seedlings were sprayed with 10 μM flavopiridol and grown on MS plates for 1 h. For the heat shock treatment, seeds were germinated and grown on MS plates for 7 days at 23 °C. The plates were moved to 17 °C for 3 days, after which time, the seedlings were subjected to a heat shock treatment for 1 h at 27 °C. The primers used for genotyping are listed in Supplementary Table S1.
+ Open protocol
+ Expand
3

Myc Phosphorylation Profiling by Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibodies used in Western blot were pThr58-Myc (Santa Cruz
Biotechnology, Dallas, Texas, sc-135647), pS62-Myc (Abcam), ERCC3 (A301-337A,
Bethyl Laboratories, Montgomery, TX); antibodies to MYC (#5605),
Rpb1-CTD (#2629), pSer2-CTD of Rpb1 (#8798), pSer2-CTD of Rpb1
(#8807), β-actin (#4967) and α-tubulin
(#2125) were purchased from Cell Signaling Technology, Danvers, MA.
Triptolide was purchased from Cayman Chemical (Ann Arbor, MI) and dissolved in
DMSO as 1 mM stock. Chemotherapy drugs were purchased from the Fox Chase Cancer
Center pharmacy.
+ Open protocol
+ Expand
4

Hypertonic Stress Response in HCT116 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCT116 cells were maintained in McCoy's medium with 10% FBS and penicillin/streptomycin. NaCl shock was performed by replacing the same medium on cells after adding NaCl from a 5 M stock and mixing. Unless otherwise indicated, NaCl was added to 230 mM, making a final concentration of monovalent cations in the medium of 350 mM. Sucrose was added to 0.63 M, which has the same osmotic pressure as 0.35 M NaCl. DRB (Sigma) was used at 100 µM, triptolide (Cayman Chemical) was used at 10 µM, α-amanitin (Sigma) was used at 5 µg/mL, and PD-169316 (MedChemExpress) was used at 15 µM.
+ Open protocol
+ Expand
5

Comparative Analysis of Androgen Receptor Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
MG132, DRB, cycloheximide, triptolide, and enzalutamide (ENZ) were purchased from Cayman Chemical Company (Ann Arbor, MI, USA). R1881 (methyltrienolone) was purchased from PerkinElmer, Inc. (Waltham, MA, USA). Bicalutamide was purchased from Thermo Fisher Scientific. Dihydrotestosterone (DHT), androstenedione (ASD), dehydroepiandrosterone (DHEA), flutamide, hydroxyflutamide (HO-Flut), and cyproterone acetate (CPA) were purchased from Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand
6

Triptolide and Flavopiridol Treatment in HEK293T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
WT HEK293T cells were grown on 6-well plates until 80 to 90% confluent. Cells were treated with triptolide (Cayman Chemicals, cat #11973-1 mg-CAY, 10 mM in DMSO) or flavopiridol hydrochloride (Cayman Chemicals, cat #10009197-5 mg-CAY, 1 mM in DMSO) a final concentration of 10 μM or 1 μM, respectively, in complete growth medium for 30 min, 1 h, and 2 h. As vehicle control, cells were treated with DMSO (diluted 1:1,000 v/v in complete medium) for 2 h. Cells were harvested using StemPro™ Accutase™ (Gibco™, cat #A1110501), resuspended in cold medium and kept on ice until further processing with CUT&Tag.
+ Open protocol
+ Expand
7

G2 Cell Cycle Synchronization Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Exponentially growing cells were pre-treated with 10 nM ATMi or DMSO as a control for 5 days, then treated for an additional 24 h in the presence (synchronised in G2 cell cycle phase) or absence (asynchronised) of 9 μM CDK1 inhibitor RO-3306 (CDK1i; Tocris Bioscience) prior to collection.
To inhibit transcription, 100 μM 5,6-dichloro-1-β-d-ribofuranosylbenzimidazole (DRB), 1 μM triptolide or 2 μg/ml α-amanitin were employed instead of CDK1i (all Cayman Chemical Company).
For antioxidant treatments, cells were treated for 72 h with ATMi, or DMSO as a control, and for an additional 72 h in the presence of 10 μM 4,5-dihydroxy-1,3-benzenedisulfonic acid (tiron) or 5 μM N-acetyl-l-cysteine (NAC) to scavenge intracellular reactive oxygen species (ROS), or with 100 U/ml catalase to scavenge extracellular ROS (all Merck). Culture medium containing ROS scavengers and ATMi, or DMSO, was replenished daily.
+ Open protocol
+ Expand
8

Antagonist Screening for Cellular Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antagonists used were as follows: 10 μm AMG9810 (Alomone, Jerusalem, Israel): a Trpv1 antagonist, 10 μm SB366791 (AdipoGen, San Diego, CA, USA): a Trpv1 antagonist, 1 μm Gö6983 (Cayman Chemical, Ann Arbor, MI, USA): a PKC antagonist, 100 nm staurosporine (LKT, St. Paul, MN, USA): a PKC antagonist, 5 μm calmidazolium (Cayman Chemical): a calmodulin antagonist, 10 μm KN93 (Cayman Chemical): a calmodulin kinase II antagonist, 3 μm KRIBB2 (Tocris Biosciences, Bristol, UK): a Hsf‐1 antagonist, 100 nm triptolide (Cayman Chemical): a Hsf‐1 antagonist, 50 μm VER155008 (Tocris Biosciences): a HSP70 antagonist, and 100 μm KNK437 (Tocris Biosciences): a HSP70 antagonist. All reagents were added into cells with a final concentration of 0.1% DMSO.
+ Open protocol
+ Expand
9

Evaluating Anticancer Small Molecules

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dinaciclib, Flavopiridol, Abemaciclib were purchased from SelleckChem. Triptolide was purchased from Cayman Chemical. 10058-F4 was purchased from Sigma. CD-532, Meriolin 3, Cdk/Crk inhibitor were obtained from the Conrad Prebys Center for Chemical Genomics at SBP.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!